• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antimicrobial activity of E-4441, a representative azetidine quinolone.

作者信息

Esteve M, Moros M, Coll R, Xicota M A, Llovera S

机构信息

Laboratorios Dr. Esteve S.A., Barcelona, Spain.

出版信息

Drugs Exp Clin Res. 1990;16(9):445-9.

PMID:2100245
Abstract

E-4441 is a third-generation difluoroquinolone characterized by the presence in position 7 of an azetidine ring, disubstituted in position 3 by amine and methyl groups. E-4322 is another difluoroquinolone which differs from the former in having a 3-acetidinol substitution in position 7. E-4441 shows satisfactory levels of activity, both in vitro and in vivo, its activity against G(+) aerobic bacteria and anaerobic bacteria being generally notable.

摘要

相似文献

1
Antimicrobial activity of E-4441, a representative azetidine quinolone.
Drugs Exp Clin Res. 1990;16(9):445-9.
2
[In vitro evaluation of lomefloxacin].[洛美沙星的体外评价]
Arzneimittelforschung. 1989 Aug;39(8):832-5.
3
In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.新型氟喹诺酮类药物E-3846对革兰氏阴性菌和革兰氏阳性菌的体外活性
Chemioterapia. 1987 Jun;6(2 Suppl):149-51.
4
In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.三种非氟喹诺酮类药物对代表性细菌分离株的体外活性。
Antimicrob Agents Chemother. 2001 Jun;45(6):1923-7. doi: 10.1128/AAC.45.6.1923-1927.2001.
5
The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.血液系统恶性肿瘤患者革兰氏阳性血流感染的范围,以及各种喹诺酮类药物对从癌症患者中分离出的革兰氏阳性菌的体外活性。
Int J Infect Dis. 2006 May;10(3):223-30. doi: 10.1016/j.ijid.2005.05.007. Epub 2006 Jan 24.
6
In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.新型含7-氮杂环丁烷环氟喹诺酮E-4868与环丙沙星、氧氟沙星和氟罗沙星的体外活性比较
Drugs Exp Clin Res. 1995;21(4):129-38.
7
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.氟喹诺酮类药物的体外活性与其体内疗效的相关性。
Drugs Exp Clin Res. 1988;14(6):375-8.
8
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.芦氟沙星(MF - 934):体内外抗菌活性
Drugs Exp Clin Res. 1989;15(1):11-5.
9
[In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].[新型氟喹诺酮类药物洛美沙星对医院菌株的体外抗菌活性。一项多中心研究的结果]
Pathol Biol (Paris). 1990 May;38(5):390-6.
10
In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.莫西沙星对台湾常见临床分离菌株的体外活性。
J Microbiol Immunol Infect. 2001 Sep;34(3):178-84.

引用本文的文献

1
Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.具有7-氮杂环丁烷环取代基的两种新型8-氯氟喹诺酮类化合物E-4767和E-5065的抗菌活性及药代动力学
Antimicrob Agents Chemother. 2001 Nov;45(11):3113-21. doi: 10.1128/AAC.45.11.3113-3121.2001.
2
Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones.四种新型7-氮杂环丁烷基氟喹诺酮类药物的抗菌活性和药代动力学
Antimicrob Agents Chemother. 1996 Jan;40(1):274-7. doi: 10.1128/AAC.40.1.274.
3
E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.
E-4695,一种新型的C-7氮杂环丁烷基氟萘啶,对革兰氏阳性菌和厌氧菌具有增强的活性。
Antimicrob Agents Chemother. 1995 Feb;39(2):413-21. doi: 10.1128/AAC.39.2.413.